Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Melissa Ann Lehr , NP-C

Nurse Practitioner โ€ข New Castle, DE

Active NPI 1902301674 Individual Practitioner Female Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

12 Reads Way Ste 2000
New Castle, DE 197201649

Call 3026528990 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

12 Reads Way Ste 2000

New Castle, DE 197201649

Telephone 3026528990
Fax 3026528646
Organization at the Same NPPES Address or Phone
Brandywine Urology Consultants Pa Facility NPI 1932132248

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Brandywine Urology Consultants Pa. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Graduation Year

2018

Medicare patients

945 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider, 2024.

Medicare-allowed amount

About $196,788 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

Paid by Medicare

About $153,386 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

30-day fills

7,215 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$644,515 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers โ€“ by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $763.30 across 45 records.

By nature of payment

  • Food and Beverage: $763.30 across 45 records.

Reporting-company totals (3 largest of 11)

  • Sumitomo Pharma America, Inc.: $293.47 across 24 records.
  • Bayer Healthcare Pharmaceuticals Inc.: $189.11 across 7 records.
  • Astellas Pharma US Inc: $52.12 across 3 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

8 years (graduated 2018)

CMS Doctors and Clinicians data list 2018 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2018

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โ€œDoes your provider accept Medicare as full payment?โ€

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Melissa Lehr has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Melissa Lehr as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in New Castle and Delaware

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Delaware (2024, 215 clinicians with data). Median for this group: 374. Middle half: 115 to 826.

Too few clinicians listed under Nurse Practitioner in New Castle have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 90% of clinicians listed under Nurse Practitioner in Delaware (2024, 215 clinicians with data). Median for this group: $27,984. Middle half: $10,072 to $59,749.

Too few clinicians listed under Nurse Practitioner in New Castle have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 90% of clinicians listed under Nurse Practitioner in Delaware (2024, 215 clinicians with data). Median for this group: $20,208. Middle half: $7,748 to $44,101.

Too few clinicians listed under Nurse Practitioner in New Castle have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 85% of clinicians listed under Nurse Practitioner in Delaware (2024, 234 clinicians with data). Median for this group: 436. Middle half: 115 to 1,455.

Too few clinicians listed under Nurse Practitioner in New Castle have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Delaware (2024, 234 clinicians with data). Median for this group: $41,940. Middle half: $2,414 to $216,454.

Too few clinicians listed under Nurse Practitioner in New Castle have Medicare Part D data for 2024 to compare.

3 active clinicians are listed under Nurse Practitioner with a practice address in New Castle, DE (552 in Delaware).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo ยท Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments ยท Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 โ€“ December 31, 2025): 45 records totaling $763.30.

Manufacturer Payment Nature Product Type Amount ($)
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $29.93
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $29.43
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
ORGOVYX General $29.32
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $28.82
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $27.71
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $27.21
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $27.19
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $26.77
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $26.64
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $26.10
UROGEN PHARMA, INC.
Food and Beverage
In-kind items and services
JELMYTO General $25.37
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $24.82
Blue Earth Diagnostics
Food and Beverage
In-kind items and services
POSLUMA General $24.23
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $24.21
Blue Earth Diagnostics
Food and Beverage
In-kind items and services
POSLUMA General $23.71
PROGENICS PHARMACEUTICALS, INC.
Food and Beverage
In-kind items and services
PYLARIFY General $23.50
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $22.86
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $22.69
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Nubeqa General $22.13
Ferring Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
ADSTILADRIN General $21.67
TOLMAR, INC.
Food and Beverage
In-kind items and services
JATENZO General $20.90
Boston Scientific Corporation
Food and Beverage
In-kind items and services
Axonics General $20.36
Ferring Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
ADSTILADRIN General $20.32
Astellas Pharma US Inc
Food and Beverage
In-kind items and services
Xtandi General $19.09
Sumitomo Pharma America, Inc.
Food and Beverage
In-kind items and services
GEMTESA General $18.58

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B ยท Data Year 2024
Reporting Year:

CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2017โ€“2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ€“ by Provider and Service data, 2018โ€“2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
87798 Detection test by nucleic acid for organism, amplified probe technique
807 86 $52.00 $34.39
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
790 631 $130.00 $76.52
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
415 335 $160.00 $107.93
51798 Ultrasound measurement of bladder capacity after voiding
410 325 $49.00 $11.10
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
362 62 $75.00 $52.57
81003 Automated urinalysis test
269 228 $25.00 $2.20
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
245 227 $100.00 $13.67
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
214 38 $75.00 $53.13
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
117 33 $65.00 $40.69
87481 Detection test for candida species (yeast), amplified probe technique
98 86 $100.00 $34.39
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
90 86 $80.00 $34.39
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
90 86 $100.00 $34.39
99427 Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month
68 31 $65.00 $40.13
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
35 35 $245.00 $138.06
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
32 32 $145.00 $94.36

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D ยท Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Tamsulosin Hcl Tamsulosin Hcl 1,001 81,935 $20,732.88 331
Myrbetriq Mirabegron 323 17,498 $261,445.50 99
Gemtesa Vibegron 262 15,971 $245,556.82 66
Oxybutynin Chloride Er Oxybutynin Chloride 219 13,074 $5,115.99 51
Finasteride Finasteride 155 12,845 $2,551.59 56
Methenamine Hippurate Methenamine Hippurate 137 9,116 $15,013.27 41
Solifenacin Succinate Solifenacin Succinate 117 7,639 $4,867.12 33
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst 97 1,686 $1,820.02 79
Cephalexin Cephalexin 92 2,273 $318.15 71
Testosterone Cypionate Testosterone Cypionate 75 3,350 $2,741.50 23
Alfuzosin Hcl Er Alfuzosin Hcl 74 5,460 $2,057.38 25
Ciprofloxacin Hcl Ciprofloxacin Hcl 71 650 $626.58 59
Testosterone Testosterone 69 3,036 $10,077.77 17
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav 69 1,091 $895.79 57
Tolterodine Tartrate Er Tolterodine Tartrate 66 3,840 $3,793.54 23
Estradiol Estradiol 63 4,488 $3,708.06 33
Cefpodoxime Proxetil Cefpodoxime Proxetil 63 371 $2,067.79 59
Desmopressin Acetate Desmopressin Acetate 40 1,156 $1,307.31 โ€”
Trospium Chloride Trospium Chloride 38 2,340 $1,790.97 17
Mirabegron Er Mirabegron 37 2,310 $25,902.31 18
Tadalafil Tadalafil 29 2,070 $2,419.94 โ€”
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim 23 277 $154.67 22
Anastrozole Anastrozole 23 1,988 $465.66 โ€”
Oxybutynin Chloride Oxybutynin Chloride 22 1,274 $479.46 โ€”
Trospium Chloride Er Trospium Chloride 22 1,200 $5,380.68 โ€”

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2026-02-27
Nurse Practitioner Primary Specialty

NUCC Taxonomy Code: 363L00000X

License # reported to NPPES DE LG-0001130

(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Delaware State Medical Licensing Board.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - NURSE PRACTITIONER

Medicare Enrollment ID

I20180423001636

Enrollment State Jurisdiction

DE

PECOS Control ID

6709149990

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Brandywine Urology Consultants Pa

12 Reads Way, New Castle, DE 197201649

Phone: 3026528990

Brandywine Urology Consultants Pa

272 Carter Dr, Middletown, DE 197095851

Phone: 3026528990

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

18 listed
Katherine Abernethy , NP-C

Nurse Practitioner - Family

NPI 1629477153

Nurse Practitioner (Certified)

Jennifer Bader , PA-C

Physician Assistant

NPI 1407163983

Physician Assistant (Certified)

NPI 1558319145

Doctor of Medicine (M.D.)

NPI 1548689037

Doctor of Medicine (M.D.)

NPI 1144278722

Doctor of Medicine (M.D.)

NPI 1265536353

Doctor of Medicine (M.D.)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

8 Historical Events
๐Ÿ“
Updated Practice Location February 27, 2026

Registered at 12 READS WAY STE 2000, NEW CASTLE, DE 197201649 (Tel: 3026528990)

๐Ÿ“
Updated Business Mailing Address February 27, 2026

Registered at 12 READS WAY STE 2000, NEW CASTLE, DE 197201649 (Tel: 3026528990)

โœ…
NPI Profile Active March 26, 2018

NPI status registered as active in NPPES database

๐Ÿ“
Practice Location (Initial Record) March 26, 2018

Registered at 2000 FOULK RD STE F, WILMINGTON, DE 198103642 (Tel: 3026528990)

๐Ÿ“
Business Mailing Address (Initial Record) March 26, 2018

Registered at 2000 FOULK RD STE F, WILMINGTON, DE 198103642 (Tel: 3026528990)

๐Ÿ‘ค
Provider Name / Credentials (Initial Record) March 26, 2018

Recorded as MELISSA LEHR, NP-C

๐ŸŽ“
Medical Taxonomy / Specialty Registered (Primary Specialty) March 26, 2018

Nurse Practitioner (license number reported to NPPES: DE LG-0001130)

๐ŸŸข
Initial NPI Registration & Enumeration March 26, 2018

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1902301674
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: March 26, 2018
Last Update: February 27, 2026
Sole Proprietor: No

Other Nurse Practitioners in New Castle

Healthcare providers in New Castle

Mailing Address

12 Reads Way Ste 2000

New Castle, DE 197201649

Phone: 3026528990

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.